Effectiveness of auriculotherapy for uncontrolled mild hypertension

Effectiveness of auriculotherapy for uncontrolled mild hypertension: a pilot randomized trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN26037089

Enrollment

Registered

2012-08-03

Start date

2007-10-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncontrolled mild hypertension Circulatory System Essential (primary) hypertension

Interventions

Group A (experimental group): The participants received an integrative approach (AT without magnetic pellet pressing plus Western medication). The magnetic pellets used in this study contained an ave

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Borderline-controlled hypertension was defined in the present study as blood pressure (BP) remaining above 140/90 mmHg even when the patient was on anti-hypertensive therapy in accordance with the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC) guideline. 2. Chinese patients with uncontrolled mild hypertension

Exclusion criteria

Exclusion criteria: 1. Secondary hypertension 2. Upper limit of BP more than 160/99 mmHg (as a precaution to exclude high-risk cases and to ensure only cases with mild hypertension were recruited) 3. Pacemakers/implanted electrical devices 4. Pregnancy 5. A history of coronary artery disease or stroke, or comorbid illnesses such as diabetes or chronic kidney disease 6. Regular maintenance medications (apart from anti-hypertensives) which may affect BP 7. Aural injuries or infections

Design outcomes

Primary

Measure	Time frame
Mean Arterial Pressure (MAP) was used as the main outcome measure in this study owing to its clinical and physiological significance in both the representation of perfusion pressure and the effect on the calculation of hemodynamic variables. After a 10-minute rest, the participants blood pressure readings were recorded using the Datascope Electronic Sphygmomanometer at baseline, at weekly visits to the clinic during the 4-week treatment course, and at 1 month and 2 months following the whole course. Datascope is one of the valid blood pressure measuring devices recently recommended by the European Society of Hypertension for clinical use in hospitals.	—

Measure

Time frame

Mean Arterial Pressure (MAP) was used as the main outcome measure in this study owing to its clinical and physiological significance in both the representation of perfusion pressure and the effect on the calculation of hemodynamic variables. After a 10-minute rest, the participants blood pressure readings were recorded using the Datascope Electronic Sphygmomanometer at baseline, at weekly visits to the clinic during the 4-week treatment course, and at 1 month and 2 months following the whole course. Datascope is one of the valid blood pressure measuring devices recently recommended by the European Society of Hypertension for clinical use in hospitals.

—

Secondary

Measure	Time frame
Self reported by the participants at the end of the treatment course and included: 1. Frequency of nocturnal polyuria 2. Perceived sleep condition 3. Calmness of mind 4. Appetite	—

Countries

Hong Kong

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026